journal article·2007-09

Elucidation of the physicomechanical and ab initio quantum energy transitions of a crosslinked PLGA scaffold

Sibongile R. Sibambo, Viness Pillay, Yahya E. Choonara, Riaz A. Khan, Joe L. Sweet

Biomaterials· Volume 28· Issue 25
Publisher page

Abstract

This study elucidated the in vitro physicomechanical transitions of a crosslinked polylactic-co-glycolic acid (PLGA) scaffold, utilizing quantum mechanics to compute the ab initio energy requirements of a salted-out and subsequently crosslinked PLGA scaffold interacting with simulated physiological fluid, phosphate buffered saline (PBS) (pH 7.4, 37 degrees C) at a molecular level. Twenty-six salted-out PLGA scaffolds were formulated using a four factor, two centerpoint quadratic Face-Centered Central Composite Design (FCCD). PLGA molecular mass, PLGA concentration, water volume and salting-out reaction time were the dependant formulation variables. Subsequent to PLGA solubilization in dimethyl formamide (DMF), protonated water was added to induce salting-out of PLGA into a scaffolds that were immersed in PBS, oscillated at 100 rpm, and analyzed at pre-determined time intervals for their physicomechanical and ab initio quantum energy transitions. Results indicated that the matrix resilience (MR) decreased with longer incubation periods (MR=35-45%) at day 30. Scaffolds salted-out using higher PLGA concentrations exhibited minimal changes in MR and the matrix ability to absorb energy was found to closely correlate with the scaffold residence time in PBS. Spartan-based ab initio quantum energy predictions elucidated the potential scaffold stability from a molecular viewpoint and its suitability for use in rate-modulated drug delivery.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (17)

Show source-provided references
1. Biodegradable polyesters for drug and polypeptide delivery
2. Potential applications of PLGA film-implants in modulating in vitro drugs release10.1016/S0378-5173(02)00431-3 ↗
3. Biodegradable microspheres as a depot system for parenteral delivery of peptide drugs10.1016/0168-3659(94)90082-5 ↗
4. Formulation in-vitro transfection efficiency of poly (d,l-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery
5. Biodegradation of aliphatic polyesters
6. Biodegradation and biocompatibility of PLA and PLGA microspheres10.1016/S0169-409X(97)00048-3 ↗
7. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application10.1081/BIO-200039635 ↗
8. Characterizing particulate drug-delivery carriers with atomic force microscopy10.1109/MEMB.2005.1384106 ↗
9. Biological activity of rhBMP-2 released from PLGA microspheres10.1115/1.429662 ↗
10. Why degradable polymers undergo surface erosion or bulk erosion10.1016/S0142-9612(02)00170-9 ↗
11. Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: is the erosion controlled by degradation, swelling or diffusion?10.1016/S0939-6411(01)00130-8 ↗
12. Hydration theory for molecular biophysics10.1016/S0065-3233(02)62011-X ↗
13. Formulation and evaluation of controlled release delivery systems for the treatment of alzheimer's disease
14. Soft contact lenses capable of sustained delivery of timolol10.1002/jps.10209 ↗
15. Cochran · 1992
16. Biomimetic mineral–organic composite scaffolds with controlled internal architecture
17. Modifying the release of gentamicin from microparticles using PLGA blends10.1081/PDT-120003491 ↗